PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-51.02%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-46.54%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.60%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-55.20%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
80.95%
Net income growth above 1.5x ADI's 0.46%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
81.13%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
81.13%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.19%
Share reduction more than 1.5x ADI's 39.26%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.19%
Diluted share reduction more than 1.5x ADI's 39.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-3.21%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
316.99%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
184.15%
FCF growth above 1.5x ADI's 21.11%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-28.67%
Negative 10Y revenue/share CAGR while ADI stands at 100.65%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-39.49%
Negative 5Y CAGR while ADI stands at 35.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-62.42%
Negative 3Y CAGR while ADI stands at 10.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
64.38%
Below 50% of ADI's 203.53%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.55%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
-185.06%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
70.38%
Below 50% of ADI's 1058.03%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-115.93%
Negative 3Y CAGR while ADI is 103.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
91.70%
10Y equity/share CAGR 1.25-1.5x ADI's 79.09%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
88.43%
5Y equity/share CAGR above 1.5x ADI's 43.12%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
33.93%
3Y equity/share CAGR 1.25-1.5x ADI's 30.05%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
1.01%
Dividend/share CAGR of 1.01% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
19.89%
Dividend/share CAGR of 19.89% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
42.45%
3Y dividend/share CAGR of 42.45% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-17.25%
Firm’s AR is declining while ADI shows 11.07%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-29.91%
Inventory is declining while ADI stands at 1.81%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.06%
Negative asset growth while ADI invests at 5.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
6.74%
Debt growth far above ADI's 3.90%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-55.80%
Our R&D shrinks while ADI invests at 1.97%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.69%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.